Celgene完成收购Juno,共同提升全球领先的细胞免疫疗法

日期:2018-03-12    来源:Businesswire       分享 :

推进成为全球细胞免疫治疗领域领先者的战略


即刻增加JCAR017晚期疗法,预计从2020年及以后呈增长趋势,其潜在的全球高峰销售额约为30亿美元


Celgene公司宣布,它已于2018年3月6日完成对Juno Therapeutics,Inc.的收购。因此,Juno的普通股将不再在纳斯达克(NASDAQ)全球精选市场上市交易。


收购Juno使Celgene成为全球领先的细胞免疫疗法企业之一,为其广泛的商业组合和治疗流程添加新技术和先进的细胞制造能力,以弥补血液学和肿瘤学领域的严重缺口。Celgene还获得JCAR017(lisocabtagene maraleucel; liso-cel)在全球的权益,就目前用于复发和/或难治性弥漫性大B细胞淋巴瘤(DLBCL)的关键试验而言,该药有望成为DLBCL的最佳CD-19靶向CART疗法。Celgene期望在Juno管线中增加JCAR017和其他细胞免疫产品,以加速其收入多元化,并从2020年及以后持续增长。


“我们Juno的同事正在开发最有前景的抗癌疗法,我们非常高兴能将他们的开拓性工作添加到Celgene领先的血液学和肿瘤学研究和商业平台中,” Celgene公司董事长兼首席执行官Mark J. Alles说。“我们将共同努力,发现、开发新疗法,改善全球患者的生活并延长他们的生命。”


延伸阅读:

关于Celgene

Celgene is building a preeminent global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for patients with cancer, immune-inflammatory, and other unmet medical needs. The organization cares deeply and works tirelessly to deliver on the mission of improving the lives of patients worldwide. The talent, scientific knowledge and research capabilities help the company to deliver access to innovative, disease-altering therapies to those who need them most. 


关于Juno

Juno is a nationwide Internet Service Provider, available in more than 8,000 cities across North America. Juno offers unlimited paid service and a Free ISP. Juno offers a variety of Internet service options. Whether you need dial-up or DSL Internet service, we provide a fast, reliable Internet connection for less than other Internet service providers. Juno Turbo internet offers accelerated dial up Internet access, with Web surfing up to five times faster than conventional dial up Internet*. The Juno High Speed Internet service works from any phone jack using a standard dial up connection and does not require any new hardware. With Turbo Internet, you can download the software and be online in minutes.


翻译:郑云莉

原文:http://www.china-pharmacy.com/314/315/27440.html

关注我们 :